We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Electroceutical Device Eases Chronic Back and Leg Pain

By HospiMedica International staff writers
Posted on 15 Dec 2014
Print article
Image: The Freedom Spinal Cord Stimulation (SCS) system (Photo courtesy of Stimwave Technologies).
Image: The Freedom Spinal Cord Stimulation (SCS) system (Photo courtesy of Stimwave Technologies).
A new injectable neuromodulation device powered by an externally worn transmitter aids in the relief of chronic back and leg pain.

The Stimwave Freedom Spinal Cord Stimulation (SCS) system is based on a tiny injectable microchip that delivers small pulses of energy to electrodes near surrounding nerves, triggering a reaction that enables the brain to remap specific pain signals, thus providing pain relief. The stimulator, which is so narrow (1.3 mm) that it can be implanted through a standard needle, eliminates the need for long electrical leads necessary in pacemaker-like devices. Containing 4 electrode arrays, the stimulator is fixed in place by a suture sleeve cap anchor, serving as a permanent, long-term device.

The SCS is powered by a wearable antenna assembly (WAA) that uses wireless radiofrequency (RF) signals; wireless Bluetooth technology is also used to program the WAA with specific stimulation parameters. For added safety, the neurostimulator only accepts communication from a specific WAA. The system also features the ability to allow the patient to have a whole body 3 T or 1.5 T magnetic resonance imaging (MRI) scan, without removing the implant. The Stimwave Freedom SCS system is a product of Stimwave Technologies (Miami Beach, FL, USA), and has been approved by the US Food and Drug Administration (FDA).

“This technology is no longer an academic-type science experiment, but a real, viable innovation that can immediately start being utilized by patients in pain,” said Laura Tyler Perryman, MSc, MBA, co-inventor of the SCS system and CEO and chairman of Stimwave Technologies. “Historically with SCS, dependency on pain medications can be drastically reduced or even eliminated.”

“I am extremely excited about this new technology developed by Stimwave and recent clearance by the FDA,” said David Kloth, MD, medical director of the Connecticut Pain Care Center and author of the book Pain Wise. “Now people in pain will have additional options including the ability to receive a permanent implant with a far less invasive and complicated surgery, while avoiding the cumbersome long-term issues with recharging, as is the case today with other systems.”

SCS, in the simplest form, consists of stimulating electrodes implanted in the epidural space. It has notable analgesic properties and, at the present, is used mostly in the treatment of failed back surgery syndrome, complex regional pain syndrome, and refractory pain due to ischemia.

Related Links:

Stimwave Technologies


New
Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
New
Portable Manual Defibrillator
RESCUE 230
New
X-Ray Image Acquisition Software
dicomPACS DX-R
New
Memory Foam Mattress
MM-59

Print article

Channels

AI

view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Surgical Techniques

view channel
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)

Category-Defining Balloon Distal Access Catheter Allows Surgeons to Get Much Closer to Blood Clots

Thrombectomy is a minimally invasive procedure for removing a blood clot and has now become standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a Large Vessel Occlusion (LVO).... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.